Literature DB >> 23600814

Tuning the precision of predictors to reduce overestimation of protein disorder over large datasets.

Antonio Deiana1, Andrea Giansanti.   

Abstract

This is a study on the precision of four known protein disorder predictors, ranked among the best-performing ones: DISOPRED2, PONDR VSL2B, IUPred and ESpritz. We address here the problem of a systematic overestimation of the number of disordered proteins recognized through the use of these predictors, considered as a standard. Some of these predictors, used with their default setting, have a low precision, implying a tendency to overestimate the occurrence of disordered proteins in genome-wide surveys. Moreover, different predictors often disagree on the evaluation of individual proteins. To cope with this problem and in order to propose a simple procedure that enhances precision based on precision-recall curves, we re-tuned the discriminative thresholds of the predictors by training and cross-validating their performance on a cured dataset. After re-tuning, both the disagreement among predictors and the tendency to overestimate the occurrence of disordered proteins are reduced. This is shown in a dedicated study over the human proteome and a set of cancer-related human proteins, with no a priori disorder annotation. Simple quantitative estimates suggest that the occurrence of disorder among cancer-related proteins and other similar large-scale surveys has been overestimated in the past.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23600814     DOI: 10.1142/S0219720012500230

Source DB:  PubMed          Journal:  J Bioinform Comput Biol        ISSN: 0219-7200            Impact factor:   1.122


  1 in total

1.  The intervening domain from MeCP2 enhances the DNA affinity of the methyl binding domain and provides an independent DNA interaction site.

Authors:  Rafael Claveria-Gimeno; Pilar M Lanuza; Ignacio Morales-Chueca; Olga C Jorge-Torres; Sonia Vega; Olga Abian; Manel Esteller; Adrian Velazquez-Campoy
Journal:  Sci Rep       Date:  2017-01-31       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.